Therefore, various migration in vitro assays were performed on a variety of GBM/GSCs lines, analyzing the growth-inhibitory effects evoked by BRAT1 inhibition, but remaining the same readout of the influence on the migration potential after CurD treatment (Suppl. The gene discussed is BRAT1; the disease is glioblastoma.